KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for Adaptive Biotechnologies (ADPT) over the last 6 years, with Q3 2025 value amounting to $20000.0.

  • Adaptive Biotechnologies' Other Non-Current Liabilities changed 0.0% to $20000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $20000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $20000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Other Non-Current Liabilities stood at $20000.0, which was down 0.0% from $20000.0 recorded in Q2 2025.
  • Adaptive Biotechnologies' Other Non-Current Liabilities' 5-year high stood at $128.2 million during Q2 2023, with a 5-year trough of $20000.0 in Q2 2024.
  • In the last 4 years, Adaptive Biotechnologies' Other Non-Current Liabilities had a median value of $20000.0 in 2024 and averaged $50.5 million.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Other Non-Current Liabilities plummeted by 9998.44% in 2024, and later changed by 0.0% in 2025.
  • Over the past 4 years, Adaptive Biotechnologies' Other Non-Current Liabilities (Quarter) stood at $125.4 million in 2022, then grew by 2.24% to $128.2 million in 2023, then plummeted by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025.
  • Its Other Non-Current Liabilities was $20000.0 in Q3 2025, compared to $20000.0 in Q2 2025 and $20000.0 in Q1 2025.